11.41
price up icon0.80%   0.09
pre-market  Pre-market:  11.28   -0.13   -1.14%
loading
Viatris Inc stock is traded at $11.41, with a volume of 4.16M. It is up +0.80% in the last 24 hours and up +2.52% over the past month. Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$11.32
Open:
$11.36
24h Volume:
4.16M
Relative Volume:
0.52
Market Cap:
$13.62B
Revenue:
$15.24B
Net Income/Loss:
$-646.50M
P/E Ratio:
7.4575
EPS:
1.53
Net Cash Flow:
$1.88B
1W Performance:
-0.52%
1M Performance:
+2.52%
6M Performance:
-3.47%
1Y Performance:
+18.12%
1-Day Range:
Value
$11.29
$11.46
1-Week Range:
Value
$11.23
$11.65
52-Week Range:
Value
$8.74
$13.62

Viatris Inc Stock (VTRS) Company Profile

Name
Name
Viatris Inc
Name
Phone
(724) 514-1465
Name
Address
1000 MYLAN BOULEVARD, CANONSBURG
Name
Employee
38,000
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
VTRS's Discussions on Twitter

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-23-23 Downgrade BofA Securities Neutral → Underperform
Jun-23-23 Downgrade Barclays Equal Weight → Underweight
Apr-24-23 Downgrade Barclays Overweight → Equal Weight
Feb-17-23 Downgrade BMO Capital Markets Outperform → Market Perform
Jan-27-23 Upgrade Jefferies Hold → Buy
Nov-10-22 Upgrade UBS Sell → Neutral
Nov-08-22 Upgrade Piper Sandler Underweight → Neutral
Oct-21-22 Resumed Jefferies Hold
Jun-14-22 Initiated UBS Sell
May-10-22 Downgrade Piper Sandler Neutral → Underweight
Mar-01-22 Downgrade BofA Securities Buy → Neutral
Mar-01-22 Downgrade Raymond James Outperform → Mkt Perform
Jun-15-21 Initiated Citigroup Neutral
Apr-07-21 Resumed RBC Capital Mkts Outperform
Mar-08-21 Downgrade Goldman Buy → Neutral
Mar-02-21 Downgrade JP Morgan Overweight → Neutral
Feb-26-21 Downgrade Wolfe Research Outperform → Peer Perform
Jan-05-21 Initiated Argus Hold
Dec-14-20 Initiated Bernstein Mkt Perform
View All

Viatris Inc Stock (VTRS) Latest News

pulisher
Oct 09, 2024

Viatris reports positive results for EFFEXOR in Japan GAD study - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Viatris reports positive results for EFFEXOR in Japan GAD study By Investing.com - Investing.com UK

Oct 09, 2024
pulisher
Oct 09, 2024

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD) - StockTitan

Oct 09, 2024
pulisher
Oct 08, 2024

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row - StockTitan

Oct 08, 2024
pulisher
Oct 08, 2024

Viatris 2023 Sustainability Report: Expanding Contractor Training - CSRwire.com

Oct 08, 2024
pulisher
Oct 08, 2024

Is Viatris Inc. (NASDAQ:VTRS) The Best NASDAQ Stock Under $20? - Insider Monkey

Oct 08, 2024
pulisher
Oct 08, 2024

Is Viatris Inc. (NASDAQ:VTRS) The Best NASDAQ Stock Under $20? - Yahoo Finance

Oct 08, 2024
pulisher
Oct 07, 2024

Novo Nordisk settles US patent fight with Viatris over Ozempic - Reuters

Oct 07, 2024
pulisher
Oct 07, 2024

Viatris 2023 Sustainability Report: Expanding Contractor Training - Yahoo Finance

Oct 07, 2024
pulisher
Oct 04, 2024

Insomnia Drug Market to Witness Huge Growth by 2024 | Sanofi, Lundbeck, Viatris - openPR

Oct 04, 2024
pulisher
Oct 03, 2024

(VTRS) On The My Stocks Page - Stock Traders Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Naloxone Market Set to Witness Significant Growth by 2024-2031:Akorn,Inc, Kaleo,Inc., Pfizer Inc, Viatris - EIN News

Oct 03, 2024
pulisher
Oct 01, 2024

Amazon.com Inc. stock outperforms competitors despite losses on the day - MSN

Oct 01, 2024
pulisher
Oct 01, 2024

Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now? - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Viatris's SWOT analysis: generic drug maker's stock faces challenges amid growth - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Viatris's SWOT analysis: generic drug maker's stock faces challenges amid growth - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment - Yahoo Finance

Sep 30, 2024
pulisher
Sep 30, 2024

Viatris to close Cork plant with 200 jobs impacted - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Access at scale for sustainable healthcare development - Vietnam Investment Review

Sep 29, 2024
pulisher
Sep 26, 2024

Piper Sandler maintains Neutral rating on Viatris stock with steady price target - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Piper Sandler maintains Neutral rating on Viatris stock with steady price target - Investing.com India

Sep 26, 2024
pulisher
Sep 25, 2024

Viatris delivering high-quality, accessible, and sustainable healthcare solutions - Vietnam Investment Review

Sep 25, 2024
pulisher
Sep 25, 2024

Anti-retroviral Drugs Market to hit USD 42.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.

Sep 25, 2024
pulisher
Sep 24, 2024

Sustainable dynamics for improved patient access - Vietnam Investment Review

Sep 24, 2024
pulisher
Sep 24, 2024

XTX Topco Ltd Boosts Stake in Virtus Investment Partners, Inc. (NASDAQ:VRTS) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Ventyx gets $27 million investment from Sanofi - The Pharma Letter

Sep 24, 2024
pulisher
Sep 23, 2024

Viatris Inc [VTRS] Stock trading around $11.39 per share: What’s Next? - The DBT News

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi investment in Ventyx shows VTX3232 interest, says H.C. Wainwright - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Barclays gives an Equal weight recommendation for Vertex Pharmaceuticals, Inc. (VRTX) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Viatris Gets Shareholders' Biosimilars Class Action Thrown Out - Bloomberg Law

Sep 23, 2024
pulisher
Sep 23, 2024

Viatris Inc (VTRS) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Is Viatris Stock Underperforming The Dow? - Barchart

Sep 23, 2024
pulisher
Sep 23, 2024

(VTRS) Technical Pivots with Risk Controls - Stock Traders Daily

Sep 23, 2024
pulisher
Sep 22, 2024

Fidelis Capital Partners LLC Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Sep 22, 2024
pulisher
Sep 21, 2024

Legacy Financial Advisors Inc. Increases Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

GM Advisory Group LLC Sells 31 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Viatris Inc (VTRS) Shares Down 5.34% on Sep 20 - GuruFocus.com

Sep 20, 2024
pulisher
Sep 20, 2024

In Europe, Packaging Site Takes Flight as a Bird-Friendly Workplace - CSRwire.com

Sep 20, 2024
pulisher
Sep 20, 2024

Viatris 2023 Sustainability Report: Health and Safety in the Workplace - CSRwire.com

Sep 20, 2024
pulisher
Sep 20, 2024

General Anesthesia Drugs Market Generated Opportunities, - openPR

Sep 20, 2024
pulisher
Sep 20, 2024

Jupiter Endovascular treats first patients with Vertex system in SPIRARE I study - Medical Device Network

Sep 20, 2024
pulisher
Sep 19, 2024

Viatris 2023 Sustainability Report: Health And Safety In The Workplace - MENAFN.COM

Sep 19, 2024
pulisher
Sep 19, 2024

In Europe, Packaging Site Takes Flight as a Bird-Friendly Workplace - AccessWire

Sep 19, 2024
pulisher
Sep 19, 2024

In Europe, Packaging Site Takes Flight as a Bird-Friendly Workplace - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system - Mass Device

Sep 19, 2024
pulisher
Sep 19, 2024

Viatris 2023 Sustainability Report: Health and Safety in the Workplace - AccessWire

Sep 19, 2024
pulisher
Sep 19, 2024

Viatris 2023 Sustainability Report: Health and Safety in the Workplace - StockTitan

Sep 19, 2024
pulisher
Sep 19, 2024

Viatris 2023 Sustainability Report: Health and Safety in the Workplace - ReportAlert.info

Sep 19, 2024
pulisher
Sep 19, 2024

China Mesalazine Market Projected To Witness Substantial Growth, 2024-2031:AbbVie Inc, GSK Plc, Novartis AG, - EIN News

Sep 19, 2024
pulisher
Sep 19, 2024

Victoria’s Secret & Co. (NYSE:VSCO) Upgraded to Equal Weight at Barclays - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

VF (NYSE:VFC) Upgraded to Overweight by Barclays - Defense World

Sep 19, 2024

Viatris Inc Stock (VTRS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$78.76
price up icon 0.01%
$111.62
price down icon 0.04%
$60.96
price up icon 0.35%
$73.24
price up icon 1.17%
$109.27
price up icon 1.08%
Cap:     |  Volume (24h):